<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2065">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361591</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2020/0384</org_study_id>
    <nct_id>NCT04361591</nct_id>
  </id_info>
  <brief_title>COVID-19 in Liver Transplant Recipients</brief_title>
  <acronym>COVID19-SETH</acronym>
  <official_title>COVID-19 in Liver Transplant Recipients in Spain: a Nationwide Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Espa침ola de Trasplante Hep치tico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective observational study aimed at analyzing the incidence, clinical characteristics
      and outcomes of COVID-19 in LT in Spain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronavirus Disease 2019 (COVID-19) is a novel viral disease caused by the SARS-Cov-2
      infection with a particular predominance of upper and lower respiratory tract symptoms. First
      diagnosed in China in late 2019, the virus has progressed to a state of pandemia, involving
      Spain with a important outbreak.

      While the outcomes of viral infections in solid organ transplant (SOT) recipients tend to be
      worse than those from the general population due to chronic immunosuppression, there is
      little information on the incidence and outcomes of COVID-19 in liver transplant (LT)
      recipients. LT recipients are usually under less immunosuppression than other SOT and the
      clinical expression and outcomes of COVID-19 may be different to the reported outcomes in
      other SOT.

      The Spanish Society of Liver Transplantation, which includes 25 LT programs, has promoted a
      nationwide registry for LT with COVID-19 to help ascertain the incidence and outcomes and
      help evidence-based management .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of COVID19 in LT recipients</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of COVID19 in LT recipients</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival and Mechanical ventilation / respiratory support</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed treatments and immunosuppression management</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <condition>COVID19</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Liver Transplant recipients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational only</intervention_name>
    <description>Observational Study</description>
    <arm_group_label>COVID-19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Liver Transplantation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver Transplant recipient

          -  Confirmed (PCR positive) SARS-Cov-2 infection

          -  Informed Consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jordi Colmenero</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sociedad Espa침ola de Trasplante Hep치tico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jordi Colmenero, MD PhD</last_name>
    <phone>+932275753</phone>
    <email>jcolme@clinic.cat;</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>SETH Scientific Committee</last_name>
    <phone>+34 933 027 541</phone>
    <email>congress@AOPC.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SETH-affiliated Liver Transplant Programs in Spain</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://www.sethepatico.org/</url>
    <description>SETH webpage</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Jordi Colmenero</investigator_full_name>
    <investigator_title>Liver Transplant Hepatologist, SETH Scientific Committee Chair</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

